| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 49.5 | 42.5 | 37.0 |
| Other income | 0.3 | 0.2 | 0.2 |
| Total income | 49.8 | 42.8 | 37.2 |
| Profit before exceptional items & tax | 9.0 | 7.1 | 4.2 |
| Profit before tax | 9.0 | 7.1 | 4.2 |
| Net profit | 6.1 | 5.1 | 3.1 |
| Operating margin | 18.1% | 16.6% | 11.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +96.80% |
|---|---|
| Net profit, quarter on quarter | +19.60% |
| Revenue, year on year | +33.80% |
BSE results filing, BSE: 544687. Figures extracted from the filing.
Hannah Joseph Hospital Ltd: key numbers
- Share price
- ₹108.00
- Market cap
- ₹245.1 Cr
- Revenue (annual)
- ₹92.05 Cr
- Net profit (annual)
- ₹11.18 Cr
- P/E (TTM)
- 21.9×Sector 57.8×
- Promoter holding
- 71.28%
- FII holding
- 0.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hannah Joseph Hospital Ltd
All →Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
- From
- Confederation of Indian Industry (CII)